Skip to main content
. 2020 Sep 7;21(18):6520. doi: 10.3390/ijms21186520
PD Parkinson’s disease
LUTS lower urinary tract symptoms
OAB overactive bladder
DO detrusor overactivity
6-OHDA 6-hydroxydopamine
KO knockout
UBP urethral baseline pressure
A-URE amplitude during electrical stimulation
MPTP 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
LB Lewy Bodies
SNCA α-synuclein
NHP non-human primates